Author: Tony Daltorio, Investors Alley

Pharmaceutical powerhouses, they’re both leading the way in the sector.

With its proven brands, emerging markets exposure, and new management team – all backed up by better-than-expected results – the future looks brighter than it has for a number of years.

With a strong multi-year growth trajectory, it’s a huge investment opportunity.

A REIT with a unique focus, Wall Street fears have created an opportunity.

Even though the sector is out of favor on Wall Street, a recently announced merger got my attention.